secwatch.observer — SEC 8-K summary
======================================

Issuer:     CONMED Corp (CNMD)
CIK:        0000816956
Form:       8-K
Filed at:   2023-07-26T23:59:59+00:00
Accession:  0001174947-23-000915
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CONMED Q2 sales +14.6% to $317.7M, adj. EPS $0.83, raises FY guidance
---------------------------------------------------------------------

- GAAP diluted EPS $0.43 vs loss of $5.65; adjusted diluted EPS $0.83, +9.2% YoY.
- Revenue $317.7M (+14.6% as reported, +16.6% constant currency); acquisitions added ~400 bps.
- Domestic sales +17.1%; International sales +11.7% as reported (+16.0% constant currency).
- Orthopedic Surgery +17.1%, General Surgery +12.6% as reported.
- FY 2023 revenue guidance raised to $1.230-1.260B; adjusted EPS guidance raised to $3.40-3.55.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/816956/000117494723000915/0001174947-23-000915-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/816956/000117494723000915/form8k-30543_cnmd.htm
  HTML page:      https://secwatch.observer/filing/0001174947-23-000915

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer